BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/28/2020 1:45:47 AM | Browse: 854 | Download: 1967
 |
Received |
|
2020-03-03 02:23 |
|
Peer-Review Started |
|
2020-03-03 02:33 |
|
First Decision by Editorial Office Director |
|
2020-07-25 18:26 |
|
Return for Revision |
|
2020-07-25 18:26 |
|
Revised |
|
2020-08-09 01:20 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-09-01 11:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-09-01 19:34 |
|
Articles in Press |
|
2020-09-01 19:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-22 09:34 |
|
Publish the Manuscript Online |
|
2020-09-28 01:45 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong Beum Kim, Hee Jeong Lee, Ran Hong and Sang-Gon Park |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning |
NRF-2017R1C1B5076793 |
| grants from the Chosun University Hospital |
2019 |
| National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning |
NRF-2017R1D1A1B04031741 |
|
| Corresponding Author |
Hee Jeong Lee, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, 365 Pilmun-daero, Dong-gu, Gwangju 505717, South Korea. hjangel21c@hanmail.net |
| Key Words |
Ovarian undifferentiated carcinoma; Sarcomatoid change; Chemotherapy; Etoposide, ifosfamide, cisplatin; Case report; |
| Core Tip |
Palliative chemotherapy is the only available treatment for metastatic ovarian undifferentiated carcinoma. However, we used a high-dose combination chemotherapy of etoposide, ifosfamide, and cisplatin instead of the widely used paclitaxel and platinum and successfully treated an extremely rare case of inoperable metastatic ovarian undifferentiated carcinoma. |
| Publish Date |
2020-09-28 01:45 |
| Citation |
Kim HB, Lee HJ, Hong R, Park SG. Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report. World J Clin Cases 2020; 8(19): 4488-4493 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i19/4488.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i19.4488 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
